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Summary Introduction
Combined factor V–factor VIII deﬁciency (F5F8D) is a
Combined factor V–factor VIII deﬁciency (F5F8D) is a
rare, autosomal recessive coagulation disorder in which
rare, recessive bleeding disorder characterized by reduction
the levels of both coagulation factor V and coagulation
in levels of both factor V and factor VIII to the range of
factor VIII are diminished. In order to map and subse-
5–20 U/dl (MIM 227310). Fewer than 100 families with
quently clone the gene responsible for this phenotype,
this disorder have been described in the literature to date
DNAs from 19 families (16 from Iran, 2 from Pakistan,
(Seligsohn and Ramot 1969; Mazzone et al. 1982; Selig-
and 1 from Algeria) with a total of 32 affected individu-
sohn et al. 1982, 1984; Ozsoylu 1983), but in societies
als were collected for a genomewide linkage search using
where consanguineous marriages are common, such as
genotypes of highly informative DNA polymorphisms.
those in the Middle East, its frequency is similar to that
All pedigrees except two contained at least one consan-
of other recessive bleeding disorders—for example, factor
guineous marriage. A maximum LOD score (Zmax) of VII deﬁciency and Glanzmann thrombasthenia. Clinically,
14.82 for uÅ .02 was generated with marker D18S1129
the severity of the bleeding ranges from mild (factor V and
in 18q21; LOD scores ú9 were obtained for several
factor VIII levels 10–20 U/dl) to moderate (5–10 U/dl)
other markers—D18S849, D18S1103, D18S64, and
(Seligsohn 1989).
D18S862. Multipoint analysis resulted in Zmax Å 18.91 Linkage to the factor V and factor VIII loci has been
for the interval between D18S1129 and D18S64. Infor-
excluded, as has linkage to components of the protein C
mative recombinants placed the locus for F5F8D be-
pathway, derangement of which might lead to excessive
tween D18S849 and D18S1103, in an interval of Ç1
destruction of the two factors deﬁcient in F5F8D (Marlar
cM. These results are similar to the recently reported
and Grifﬁn 1980; Canﬁeld and Kisiel 1982; Suzuki et al.
linkage of this disease to chromosome 18q in Jewish
1983; Gardiner and Grifﬁn 1984; Rahim et al. 1985; Zi-
families (Nichols et al. 1997) and provide evidence that
velin et al. 1995). We collected 16 F5F8D families from
the same gene is responsible for all F5F8D among hu-
Iran, 2 of Pakistani origin, and 1 from Algeria, in order
man populations. The difference in clinical severity of
to perform a genomewide linkage analysis as a ﬁrst step
the phenotype in unrelated families, as well as the failure
toward the identiﬁcation of the gene responsible for the
to detect a speciﬁc haplotype of DNA polymorphisms
phenotype. In the course of collecting the families in Iran
in the consanguineous Iranian families, suggests the exis-
and as a result of obtaining detailed clinical histories and
tence of different molecular defects in the F5F8D gene.
factor-assay levels of extended kindreds, it became appar-
There exists an apparently gap-free contig with CEPH
ent that severity varies between families but is consistent
YACs linking the two markers on either side of the
within a given family. Also, one individual with a severe
critical region. Positional cloning efforts are now in
form of the disorder (factor V and factor VIII levels of 2 U/
progress to clone the F5F8D gene.
dl) was encountered. These are new clinical observations,
which strongly suggest genetic heterogeneity.
During the course of the study, Nichols et al. (1996)
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Figure 1 Pedigrees with F5F8D that were used for linkage analysis. Haplotypes for nine markers on 18q, generated by the Cyrillic
program, are shown. Representative bars are depicted only for those families in which both parents and children were analyzed and in which
haplotypes for polymorphic markers could be constructed. All consanguineous marriages involve ﬁrst cousins, except for B1 (the mother of I-
1 and the father of I-2 are half-sibs). Families 4(a) and 4(b) are also related; the two fathers are brothers, and the two mothers are sisters. The
phase of certain genotypes is unknown, and these are indicated by question marks (?) on both sides of the numbered alleles. Question marks
without numbers denote unknown genotypes.
notype among families and the lack of a speciﬁc haplotype Families, Material, and Methods
of DNA polymorphisms in the Iranian families suggest
Familiesallelic heterogeneity; that is, more than one mutation in the
F5F8D gene is responsible for the phenotype in different Blood was collected from 16 families from Iran (A1–
A12 and A14–A17), 2 families of Pakistani origin (A18families. Positional cloning efforts to isolate the elusive
F5F8D gene are now in progress. and A19), and 1 family of Algerian origin (B1) (ﬁg. 1).
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Appropriate informed consent was obtained from all of allele frequency did not signiﬁcantly alter the estimated
LOD scores.these families. All families except A14 and A16 were
characterized by at least one consanguineous marriage.
Factor V and factor VIII assays were performed by a Results
one-stage procedure using congenitally deﬁcient plasma
Results of pairwise linkage analyses between the phe-
substrates and normal pooled plasma as reference (Dacie
notype of F5F8D families A1–A19 and B1 and 11 18q
and Lewis 1995, p. 329). The levels of factor V and
markers are shown in table 2. Zmax Å 14.82 was ob-factor VIII measured in affected individuals are shown
tained for marker D18S1129 at recombination fraction
in table 1.
u Å .02. Several other markers in this chromosomal
region (18q21) also yielded Zmax values ú9.00 for uDNA Polymorphism and Linkage Analysis õ .05. Results of multipoint linkage analysis for markers
Genomic DNA was puriﬁed from blood lymphocytes,
D18S849, D18S1129, and D18S64 are shown in ﬁgure
according to a standard SDS–proteinase K and phenol/
2, indicating Zmax Å 18.91 in the interval betweenchloroform extraction method (Kunkel et al. 1977). DNA
D18S1129 and D18S64. The chromosomal order of
polymorphisms were analyzed by PCR ampliﬁcation of
markers used had been determined elsewhere, either by
simple sequence repeats. Microsatellite markers located
linkage mapping (Murray et al. 1994; Shefﬁeld et al.
in 18q (D18S535, D18S851, D18S858, D18S849,
1995; GDB at http://gdbwww.gdb.org or CHLC at
D18S1129, D18S1103, D18S1155, D18S64, D18S862,
http://www.chlc.org:80/data/CHLCmaps) or by physi-
D18S1270, and D18S541, ordered from centromere to
cal mapping using sequence-tagged sites on YACs (Co-
telomere) were used. Information about the oligonucleo-
hen et al.1993; Hudson et al. 1995; MIT at http://www-
tide primers used for the scoring of genotypes of these
genome.wi.mit.edu/). Their order is schematically
markers and their mapping position can be obtained from
shown in ﬁgure 3.
the Genome Database (GDB) (http://gdbwww.gdb.org/)
Since most of the families are consanguineous, it
or Cooperative Human Linkage Center (http://
would be expected that the markers close to the F5F8D
www.chlc.org:80/data/CHLCmaps). Oligonucleotides
locus would show homozygosity for their alleles. For
were obtained from Research Genetics. One oligonucleo-
marker D18S1129 there are only two families (A3 and
tide primer of each marker pair was labeled with g32P-
A5) without homozygosity in the affected individuals.
ATP by use of T4 polynucleotide kinase. PCR was per-
For marker D18S1103 there are four such families (A1,
formed on a Perkin-Elmer thermocycler to amplify geno-
A5, A7, and A12). Similarly, for marker D18S849 the
mic DNA in a total volume of 15 ml mixture/reaction,
families with heterozygosity are A2, A3, A5, and B1.
containing 0.4 pM labeled forward primer, 2.6 pM unla-
The haplotypes generated by the Cyrillic program, for
beled reverse primer, 1.3 mM each dNTP, and 0.25 U
nine markers, are depicted in ﬁgure 1. Representative bars
Taq polymerase. PCR products were separated by elec-
are shown only for those families in which both parents
trophoresis in a 6% denaturing urea/polyacrylamide gel.
and children were analyzed and in which haplotypes
Scoring of the polymorphic alleles was performed across
therefore could be unequivocally constructed. Informa-
families (i.e., the allele numbering was consistent
tive recombinants were observed in a number of families.
throughout the families), for all markers except D18S849
Of particular importance were two crossovers observed
and D18S541.
in families A1 and A3. Recombination was found for
Family information and marker genotypes were
individual A1-IV5, placing the F5F8D locus distal to
stored in pedigree computer program CyrillicTM (Cher-
D18S849 (ﬁg. 1), and for individual A3-IV3, placing this
well Scientiﬁc). Analysis was performed by use of
locus proximal to D18S1103 (unfortunately, marker
the ILINK, MLINK, and LINKMAP programs of the
D18S1129 was uninformative in this family). The region
LINKAGE version 5.2 (Lathrop et al. 1984) and
between the two markers D18S849 and D18S1103 on
FASTLINK version 3.0 (Cottingham et al. 1993) soft-
chromosome 18q21 corresponds to a distance of Ç1 cM
ware packages. Multipoint linkage analysis was per-
and is entirely covered by YAC contig WC18.4 (Hudson
formed with the help of the computer facility of the
et al. 1995; MIT web page at http://www-genome.wi
U.K. Human GenomeMapping Program resource centre
.mit.edu/). Between them, YACs 789F3, 962C11,
(http://www.hgmp.mrc.ac.uk/). A Zmax was calculated 715H10, 949B6, and 826H9 contain the entire critical
for each marker locus by assuming both autosomal re-
region as deﬁned by our linkage data (ﬁg. 3).
cessive mode of inheritance with 100% penetrance and
a mutant gene frequency of .00001. For all markers, the
Discussion
allele frequencies were kept equal. Allele-frequency data
from the GDB (collected from Europe and the northern We have described here the mapping of a locus for
F5F8D to an Ç1-cM region of 18q21. The Zmax obtainedUnited States) were not used, because our study popula-
tion was mainly Iranian. In addition, slight differences in by use of DNAs from the members of 19 families of Ira-
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Table 1
Severity of Bleeding, and Factor V and Factor VIII Values, in Affected Members of F5F8D Families
Family and
Individual Severity Factor Va Factor VIIIa S1129–S1103 Haplotypeb
A1:
IV1 Moderate 8 5.5 5 4/5 5
IV4 Moderate 7 14 5 4/5 5
IV6 Moderate 11 9 5 4/5 5
A2:
IV1 Moderate 7.5 7 4 3/4 3
A3:
IV4 Mild 20 16 5 5/3 5
A4:
IV7 Moderate 10.5 11 3 3/3 3
A5:
III4 Moderate 5 10 5 5/1 3
A6:
III1 Moderate 12 12.5 4 5/4 5
III2 Moderate 12 14 4 5/4 5
A7:
III1 Moderate 7 7 5 1/5 7
A8:
III2 Moderate/severe 5 6 5 8/5 8
A9:
III2 Moderate 18 8 7 5/7 5
A10:
III1 Moderate 12 15 6 2/6 2
III4 Moderate 19 16 6 2/6 2
A11:
IV4 Mild 18 17 1 5/1 5
A12:
III3 Severe 2.5 2.2 4 3/4 6
A14:
III3 Moderate 10 6 4 3/4 3
III5 Moderate 10 13.5 4 3/4 3
III8 Moderate 10 6 4 3/4 3
III16 Moderate 10 21 1 2/6 3
A16:
II7 Mild 9 13.5 5 1/5 1
A17:
III1 Moderate 5 7.5 5 1/5 1
IV1 Moderate 34 14.5 5 1/5 1
IV2 Moderate 10 8 5 1/5 1
A18:
II3 Moderate 10 15 6 5/6 5
A19:
II1 Mild 14 14 5 2/5 2
II2 Mild 14 14 5 2/5 2
B1:
II1 Mild 24 15 8 4/8 4
a Assays were performed according to standard procedures (see Families, Material, and Methods).
b For markers D18S1129 and D18S1103, which are closely linked to the F5F8D locus.
nian, Pakistani, and Algerian origin was 14.82, for marker involved) among different human populations. However,
both the observation of different haplotypes of polymor-D18S1129. Linkage of the F5F8D locus to chromosome
phic sites in the affected individuals and the variable clini-18q in nine Jewish families has been reported recently
cal phenotype suggest allelic heterogeneity in which differ-(Nichols et al. 1996, 1997). Our data are in agreement
ent mutations in the same gene may account for thesewith those obtained by this latter study, implying that the
disease is genetically homogeneous (i.e., the same gene is ﬁndings.
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Table 2
Two-Point LOD Scores for All F5F8D Families Studied, for 11 18q Polymorphic markers
LOD SCORE AT u Å
LOCUS .0 .001 .01 .05 .1 .2 .3 .4 Zmax (u) a
D18S535 0 013.69 05.3 .06 1.51 1.71 1.06 .41 1.82 (.155)
D18S851 .90 3.80 7.14 8.40 7.74 5.44 3.10 1.21 8.41 (.046)
D18S858 0 2.84 6.37 7.77 7.24 5.11 2.88 1.08 7.77 (.05)
D18S849 0 8.37 10.83 11.26 10.08 6.98 4.00 1.59 11.42 (.031)
D18S1129 11.59 13.17 14.65 14.30 12.66 8.78 5.05 2.01 14.82 (.02)
D18S1103 0 4.62 8.03 9.26 8.53 5.97 3.33 1.20 9.27 (.045)
D18S1155 0 4.69 6.41 6.83 6.14 4.19 2.32 .91 6.88 (.035)
D18S64 8.50 9.90 11.41 11.31 10.03 6.97 4.05 1.65 11.64 (.023)
D18S862 4.04 6.24 8.69 9.36 8.49 5.94 3.43 1.39 9.43 (.037)
D18S1270 015.88 09.57 03.17 .87 1.90 1.83 1.11 .44 2.04 (.138)
D18S541 0 03.84 .64 2.99 3.16 2.35 1.38 .56 3.19 (.082)
NOTE.—Linkage analysis was performed with consanguinity loops included, by use of the MLINK and ILINK programs of the LINKAGE
software package. For all markers, the allele frequencies were kept equal.
a Calculated under the assumption of an autosomal recessive mode of inheritance with 100% penetrance.
One observation of interest concerns the presence of although there are no apparent recombinants between
the phenotype and the markers studied. One plausibletwo different alleles for the closely linked polymorphic
loci in affected individuals from consanguineous mar- explanation for this phenomenon is that the linkage
program scores the presence of historical recombi-riages involving ﬁrst cousins (e.g., for marker
D18S1129, individual A5-III4). For a rare, autosomal
recessive phenotype and markers so close to the disease
locus, this is unexpected. In the linkage analysis, the
LOD scores in this family do not maximize at u Å 0,
Figure 3 Schematic representation of a partial linkage map of
11 microsatellite markers located in 18q, around the mapping position
of the F5F8D locus. The mapping order, genetic distances (in cM),
and positions of CEPH YACs spanning the critical F5F8D locus were
obtained from the MIT mapping project Webpage (http://www-Figure 2 Multipoint analysis for markers D18S849, D18S1129,
and D18S64. Linkage analysis was performed by use of the LINKMAP genome.wi.mit.edu). Black dots in the YACs denote the presence of the
corresponding markers; unblackened circles denote nonpolymorphicprogram. The distances used were 1 cM between D18S849 and
D18S1129 and 2 cM between D18S1129 and D18S64. DNA segments linking the corresponding YACs.
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for computer support. M.N.-A. is a recipient of a Marie-Heim
LOD score maximized at u Å 0 for D18S1129 (data Voegtlin grant from the Swiss National Science Foundation.
not shown). All LOD scores shown in this study were This study was supported by NIH grant HL38165 and funds
calculated with all consanguinity loops included, and from the University and Cantonal Hospital of Geneva.
therefore the LOD scores are quite probably underesti- E.G.D.T. is supported by the U.K. Medical Research Council.
mated. Another possibility is that there are two differ-
ent mutations in the F5F8D locus in these families and References
that the consanguinity (which is common in these pop-
Antonarakis SE, Kazazian HH Jr, Tuddenham EGD (1995)ulations) is irrelevant.
Molecular etiology of factor viii deﬁciency in haemophiliaIn the families that we studied there is no apparent
A. Hum Mut 5:1–22correlation between the haplotypes for polymorphic
Canﬁeld WM, Kisiel W (1982) Evidence of normal functionalsites and the severity of the disease, suggesting that dif-
levels of activated protein C inhibitor in combined factor
ferent independent mutations are responsible for similar V/VIII deﬁciency disease. J Clin Invest 70:1260–1272
F5F8D phenotypes. This is not unexpected and else- Cohen D, Chumakov I, Weissenbach J (1993) A ﬁrst-genera-
where has been found in numerous monogenic disor- tion physical map of the human genome. Nature 366:698–
ders, including hemophilia A (Antonarakis et al. 1995). 701
In addition, comparison of haplotypes associated with Cottingham RW Jr, Idury RM, Scha¨ffer AA (1993) Faster
sequential genetic linkage computations. Am J Hum Genet‘‘affected’’ F5F8D alleles vis-a`-vis those of ‘‘nonaf-
53:252–263fected’’ chromosomes from the Iranian families exam-
Cripe LD, Moore KD, Kane WH (1992) Structure of the geneined did not reveal any differences, suggesting that dif-
for human coagulation factor V. Biochemistry 31:3777–ferent disease mutations had occurred in the common
3785haplotypes of this population. In contrast, the results of
Dacie JV, Lewis SM (eds) (1995) Practical haematology, 8ththe haplotype analysis from the study by Nichols et al.
ed. Churchill Livingstone, London
(1997), in eight unrelated but consanguineous Jewish Gardiner JE, Grifﬁn JH (1984) Studies on human protein C
families, strongly indicated a common founder effect. inhibitor and factor V/VIII deﬁcient plasmas. Thromb Res
A single-gene defect causing deﬁciency of proteins en- 36:197–203
coded by two other loci raises a number of intriguing Gitschier J, Wood WI, Goralka TM, Wion KL, Chen EY,
mechanistic explanations. Since factor V and factor VIII Eaton DH, Vehar GA, et al (1984) Characterization of the
human factor VIII gene. Nature 312:326–330are highly similar in structure and function, having
Hudson TJ, Stein LD, Gerety SS, Ma J, Castle AB, Silva J,clearly diverged from a common ancestor (Gitschier et
Slonim DK, et al (1995) An STS-based map of the humanal. 1984; Cripe et al. 1992), one may propose several
genome. Science 270:1945–1954types of candidate genes, including the following: a
Kunkel LM, Smith KD, Boyer SH, Borgaonkar DS, Wachtelhighly speciﬁc transcription regulator, a speciﬁc protein-
SS, Miller OJ, Breg WR, et al (1977) Analysis of human Y-processing factor (both factor V and factor VIII have
chromosome speciﬁc reiterated DNA in chromosome vari-
highly glycosylated B-domains), a secretion-pathway ants. Proc Natl Acad Sci USA 4:1245–1249
factor, a chaperone, or a protein involved in the extracel- Lathrop GM, Lalouel JM, Julier C, Ott J (1984) Strategies for
lular life of these factors. multilocus linkage analysis in humans. Proc Natl Acad Sci
We have localized the F5F8D critical region to an USA 81:3443–3446
Ç1-cM region of 18q, between markers D18S849 and Marlar RA, Grifﬁn JH (1980) Deﬁciency of protein C inhibitor
in combined factor V/VIII deﬁciency disease. J Clin InvestD18S1103. This region is entirely spanned by YAC con-
66:1186–1189tig WC18.4 (MIT at http://www-genome.wi.mit.edu/),
Mazzone D, Fichera A, Pratico G, Sciacca F (1982) Combinedwith YACs 789F3, 962C11, 715H10, 949B6, and
congenital deﬁciency of factor V and factor VIII. Acta826H9 containing, between them, all of the critical re-
Haematol 68:337–338gion as deﬁned by our data. Positional cloning efforts
Murray J, Buetow K, Weber J, Lugwidsen S, Scherpbier-Hed-(exon trapping, cDNA selection, and sequence sam-
dema T, Manion F, Quillen J, et al (1994) A comprehensive
pling) are now in progress to clone the F5F8D gene. human linkage map with centimorgan density. Science 265:
2049–2054
Nichols WC, Seligsohn U, Zivelin A, Terry VH, Arnold ND,Acknowledgments
Siemieniak DR, Ginsburg D (1996) The gene for combined
factors V and VIII deﬁciency maps to a 2.4 cM region onWe thank all members of these families for their cooperation
and for donating blood samples for our study. We are grateful chromosome 18. Blood Suppl 88:656a
/ 9a2d$$jy12 07-08-97 13:57:27 ajhga UC-AJHG
150 Am. J. Hum. Genet. 61:143–150, 1997
Nichols WC, Seligsohn U, Zivelin A, Terry VH, Arnold ND, (1984) Decreased factor VIII clotting antigen levels in
Siemieniak DR, Kaufman RJ, et al (1997) Linkage of com- the combined factor V and factor VIII deﬁciency. Thromb
bined factors v and viii deﬁciency to chromosome 18q by Res 33:95–98
homozygosity mapping. J Clin Invest 99:596–601 Shefﬁeld VC, Weber JL, Buetow KH, Murray JC, Even DA,
Ozsoylu S (1983) Combined congenital deﬁciency of factor V Wiles K, Gastier JM, et al (1995) A collection of tri- and
and factor VIII. Acta Haematol 70:207–208 tetranucleotide repeat markers used to generate high quality,
Rahim Adam KA, El Seed A, Karrar Z A, Gader AMA (1985) high resolution genome-wide linkage maps. HumMol Genet
Combined factor V and factor VIII deﬁciency with normal 4:1837–1844
protein C and protein C inhibitor: a family study. Scand J
Suzuki K, Nishioka J, Hashimoto S, Kamiya T, Saito HHaematol 34:401–405
(1983) Normal titer of functional and immunoreactiveSeligsohn U (1989) Combined factor V and factor VIII deﬁ-
protein C inhibitor in plasma of patients with congenitalciency. In: Seghatchian J, Savidge GT (esds) Factor VIII-von
combined factor V and factor VIII deﬁciency. Blood 62:Willebrand factor. CRC Press, New York, pp 89–100
1266–1270Seligsohn U, Ramot B (1969) Combined factor V and factor VIII
Zivelin A, Yatuv R, Seligsohn U (1995) Combined factor Vdeﬁciency: report of four cases. Br J Haematol 16:475–486
and factor VIII deﬁciency is probably not related to geneticSeligsohn U, Zivelin A, Zwang E (1982) Combined factor V
disorders of components of the protein C system. Thromband factor VIII deﬁciency among non-Ashkenazi Jews. N
Engl J Med 307:1191–1195 Haemost 73:1439
/ 9a2d$$jy12 07-08-97 13:57:27 ajhga UC-AJHG
